Progressive familial intrahepatic cholestasis: A personal perspective

Pediatric and Developmental Pathology

Volumn 3, Issue 2, 2000, Pages 113-125

  Knisely, A S ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Acids, bile; Histology; Intrahepatic cholestasis; Liver; Microscopy, electron; Proteins, transport

Indexed keywords

BILE ACID; GAMMA GLUTAMYLTRANSFERASE;

DISEASE CLASSIFICATION; ELECTRON MICROSCOPY; GENE MUTATION; GENETIC ANALYSIS; HISTOLOGY; HUMAN; INTRAHEPATIC CHOLESTASIS; PRIORITY JOURNAL; PROTEIN TRANSPORT; REVIEW;

ADENOSINE TRIPHOSPHATASES; ATP-BINDING CASSETTE TRANSPORTERS; CHOLESTASIS, INTRAHEPATIC; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; INFANT; INFANT, NEWBORN;

EID: 0034005389     PISSN: 10935266     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100249910021     Document Type: Review

References (100)

1. Hostetler JA. Amish Society, 4th ed. Baltimore: Johns Hopkins University Press, 1993.
2. Beiler AR. Family History and Genealogy of Pioneer Jacob Beiler (1698-1771): Beiler - Boiler - Byler, the Early Generations - Plus. Morgantown, PA: Masthof Press, 1998.
3. McKusick VA. Medical Genetic Studies of the Amish: Selected Papers. Baltimore: Johns Hopkins University Press, 1978.
4. Clayton RJ, Iber FL, Ruebner BH, McKusick VA. Byler disease: fatal familial intrahepatic cholestasis in an Amish kindred. Am J Dis Child 1969;117:112-124.
5. Linarelli LG, Williams CN, Phillips MJ. Byler's disease: fatal intrahepatic cholestasis. J Pediatr 1972;81:484-492.
6. Phillips MJ, Poucell S, Patterson J, Valencia P. The Liver. An Atlas and Text of Ultrastructural Pathology. New York: Raven Press, 1987.
7. Ruebner BH, Montgomery CK, French SW. Diagnostic Pathology of the Liver and Biliary Tract, 2nd ed. New York: Hemisphere Publishing Corporation, 1991.
8. Ruebner B. The pathology of neonatal hepatitis. Am J Pathol 1960;35:151-163.
9. Summerskill WHJ, Walshe JM. Benign recurrent intrahepatic 'obstructive' jaundice. Lancet 1959;ii:686-690.
10. Maggiore G, Bernard O, Hadchouel M, Lemonnier A, Alagille D. Diagnostic value of serum gamma-glutamyl transpeptidase activity in liver diseases in children. J Pediatr Gastroenterol Nutr 1991;12:21-26.
11. Tygstrup N, Steig BA, Juijn JA, Bull LN, Houwen RHJ. Recurrent familial intrahepatic cholestasis in the Faeroe Islands: phenotypic heterogeneity but genetic homogeneity. Hepatology 1999;29:506-508.
12. Sharp HL, Bridges RA, Krivit W, Freier EF. Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder. J Lab Clin Med 1969;73:934-939.
13. 1-antitrypsin in childhood liver disease. Pediatrics 1970;46:921-925.
14. Aagenaes Ø, Sigstad H, Bjoørn-Hansen R. Lymphoedema in hereditary recurrent cholestasis from birth. Arch Dis Child 1970;45:690-695.
15. Alagille D, Habib EC, Thomassin N. L'atrésie des voies biliaires intrahépatiques avec voies biliaires extrahépatiques perméables chez l'enfant (à propos de 25 observations). In: Royer P, ed. Journées Parisiennes de Pédiatrie. Paris; Flammarion, 1969;301-318.
16. Watson GH, Miller V. Arteriohepatic dysplasia: familial pulmonary arterial stenosis with neonatal liver disease. Arch Dis Child 1973;48:459-466.
17. 1-antitrypsin deficiency and neonatal hepatitis. BMJ 1972;iii:435-439.
18. Aagenaes Ø, van der Hagen CB, Refsum S. Hereditary recurrent intrahepatic cholestasis from birth. Arch Dis Child 1968;43:646-657.
19. Novotny NM, Zetterman RK, Antonson DL, Vanderhoof JA. Variation in liver histology in Alagille's syndrome. Am J Gastroenterol 1981;75:449-450.
20. Dahms BB, Petrelli M, Wyllie R, et al. Arteriohepatic dysplasia in infancy and childhood: a longitudinal study of six patients. Hepatology 1982;2:350-358.
21. Alagille D, Estrada A, Hadchouel M, Gautier M, Odièvre M, Dommergues JP. Syndromic paucity of interlobular bile ducts (Alagille syndrome or arteriohepatic dysplasia): review of 80 cases. J Pediatr 1987;110:195-200.
22. Jørgensen MJ. The ductal plate malformation. Acta Pathol Microbiol Scand A Suppl 1977;257:1-88.
23. Ballow M, Margolis CZ, Schachtel B, Hsia YE. Progressive familial intrahepatic cholestasis. Pediatrics 1973;998-1007.
24. de Vos R, de Wolf-Peeters C, Desmet V, Eggermont E, Van Acker K. Progressive intrahepatic cholestasis (Byler's disease): case report. Gut 1975;16:943-950.
25. Lovisetto P, Ferraris R, Marchi L, Mairano D, Colombo ML, Magnetti L. La colestasi intraepatica progressiva familiare: Byler's disease. Minerva Med 1979;70:3763-3781.
26. Saito K, Matsumoto S, Yokoyama T, Okaniwa M, Kamoshita S. Pathology of chronic vitamin E deficiency in fatal familial intrahepatic cholestasis (Byler disease). Virchows Arch A Pathol Anat Histopathol 1982;396:319-330.
27. Razemon-Pinta M, Lecomte-Houcke M, Mary JP, Loreille GA. La maladie de Byler (cholestase familiale fibrogène de l'enfant): à propos de 7 cas. Pédiatrie 1988;43:361-370.
28. Winklhofer-Roob BM, Shmerling DH, Solèr R, Briner J. Progressive idiopathic cholestasis presenting with profuse watery diarrhoea and recurrent infections (Byler's disease). Acta Paediatr 1992;81:637-640.
29. Jacquemin E, Dumont M, Bernard O, Erlinger S, Hadchouel M. Evidence for defective primary bile acid secretion in children with progressive familial intrahepatic cholestasis (Byler disease). Eur J Pediatr 1994;153:424-428.
30. Kagalwalla AF, Al Amir AR, Khalifa A, Sylven M, Al Ajaji S, Kagalwalla YA. Progressive familial intrahepatic cholestasis (Byler's disease) in Arab children. Ann Trop Paediatr 1995;15:321-327.
31. Landing BH. Considerations of the pathogenesis of neonatal hepatitis, biliary atresia and choledochal cyst - the concept of infantile obstructive cholangiopathy. Prog Pediatr Surg 1974;6:113-139.
32. Ishii H, Ebihara Y, Okuno F, Munakata Y, Takagi T, Arai M, Shigeta S, Tsuchiya M. γ-glutamyl transpeptidase activity in liver of alcoholics and its localization. Alcohol Clin Exp Res 1986;10:81-85.
33. Wright K, Christie DL. Use of γ-glutamyl transpeptidase in the diagnosis of biliary atresia. Am J Dis Child 1981;135: 134-136.
34. Platt MS, Potter JL, Boeckman CR, Jaberg C. Elevated GGTP/SGOT ratio: an early indicator of infantile obstructive cholangiopathy. Am J Dis Child 1981;135:834-836.
35. Fung KP, Lau SP. γ-glutamyl transpeptidase activity and its serial measurement in differentiation between extrahepatic biliary atresia and neonatal hepatitis. J Pediatr Gastroenterol Nutr 1985;4:208-213.
36. Maggiore G, Bernard O, Riely CA, Hadchouel M, Lemonnier A, Alagille D. Normal serum gamma-glutamyl-transpeptidase activity identifies groups of infants with idiopathic cholestasis with poor prognosis. J Pediatr 1987;111:251-252.
37. Chobert MN, Bernard O, Bulle F, Lemmonier A, Guellaen G, Alagille D. High hepatic γ-glutamyltransferase (γ-GT) activity with normal serum γ-GT in children with progressive idiopathic cholestasis. J Hepatol 1989;8:22-25.
38. Whitington PF, Freese DK, Alonso EM, Schwarzenberg SJ, Sharp HL. Clinical and biochemical findings in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 1994;18:134-141.
39. Lachaux A, Loras-Duclaux I, Bouvier R, Dumontet C, Hermier M. Benign recurrent cholestasis with normal gamma-glutamyl-transpeptidase activity. J Pediatr 1992; 121:78-80.
40. Nielsen I-M, Ørnvold K, Jacobsen BB, Ranek L. Fatal familial cholestatic syndrome in Greenland Eskimo children. Acta Paediatr Scand 1986;75:1010-1016.
41. Suchy FJ. Urinary bile acids: a noninvasive measure of liver function and bile acid metabolism [editorial]? J Pediatr Gastroenterol Nutr 1984;3:649-651.
42. Clayton PT, Leonard JV, Lawson AM, et al. Familial giant cell hepatitis associated with synthesis of 3β,7α-dihydroxy-and 3β,7α,12α-trihydroxy-5-cholenoic acids. J Clin Invest 1987;79:1031-1038.
43. 4-3-oxosteroid 5β-reductase deficiency described in identical twins with neonatal hepatitis: a new inborn error in bile acid synthesis. J Clin Invest 1988;82:2148-2157.
44. 5-bile acids: a new inborn error of metabolism. J Clin Invest 1990;86:2034-2037.
45. 27-steroid dehydrogenase/isomerase deficiency. J Pediatr 1994;125:379-384.
46. Clayton PT, Casteels M, Mieli-Vergani G, Lawson AM. Familial giant cell hepatitis with low bile acid concentrations and increased urinary excretion of specific bile alcohols: a new inborn error of bile acid synthesis? Pediatr Res 1995;37:424-431.
47. Setchell KDR, Schwarz M, O'Connell NC, et al. Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7α-hydroxylase gene causes severe neonatal liver disease. J Clin Invest 1998;102:1690-1703.
48. Riely CA. Familial intrahepatic cholestasis syndromes. In: Suchy FJ, ed. Liver Disease in Children. St. Louis: Mosby-Year Book, 1994;443-459.
49. Tazawa Y, Yamada M, Nakagawa M, Konno T, Tada K. Bile acid profiles in siblings with progressive familial intrahepatic cholestasis: absence of biliary chenodeoxycholate. J Pediatr Gastroenterol Nutr 1985;4:32-37.
50. Jacquemin E, Dumont M, Bernard O, Erlinger S, Hadchouel M. Evidence for defective primary bile acid secretion in children with progressive familial intrahepatic cholestasis. Eur J Pediatr 1994;153:424-428.
51. Schuler F. Endemisches Auftreten von Leberzirrhose im frühen Kindesalter. Arch Kinderheilk 1942;126:5-30.
52. Müller T, Feichtinger H, Berger H, Müller W. Endemic Tyrolean infantile cirrhosis: an ecogenetic disorder. Lancet 1996;347:877-880.
53. Joshi VV. Indian childhood cirrhosis. Perspect Pediatr Pathol 1987;11:175-192.
54. Tanner MS. Indian childhood cirrhosis and Tyrolean childhood cirrhosis: disorders of a copper transport gene? Adv Exp Med Biol 1999;448:127-137.
55. Gupta V, Mudgil A, Srivastava A, Rathi AK. Serum gamma glutamyl transferase in Indian childhood cirrhosis. J Indian Med Assoc 1983;80:6-7.
56. Phillips MJ, Ackerley CA, Superina RA, Roberts EA, Filler RM, Levy GA. Excess zinc associated with severe progressive cholestasis in Cree and Ojibwa-Cree children. Lancet 1996;347:866-868.
57. Weber AM, Tuchweber B, Yousef I, et al. Severe familial cholestasis in North American Indian children: a clinical model of microfilament dysfunction? Gastroenterology 1981;81:653-662.
58. Di Rocco M, Callea F, Pollice B, Faraci M, Campiani F, Borrone C. Arthrogryposis, renal dysfunction and cholestasis syndrome: report of five patients from three Italian families. Eur J Pediatr 1995;154:835-839.
59. de Vree JML, Jacquemin E, Sturm E, et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci USA 1998;95:282-287.
60. Holve S, Hu D, Shub M, Tyson RW, Sokol RJ. Liver disease in Navajo neuropathy. J Pediatr 1999;135:482-493.
61. Aagenaes Ø. Hereditary cholestasis with lymphoedema (Aagenaes syndrome, cholestasis-lymphoedema syndrome): new cases and follow-up from infancy to adult age. Scand J Gastroenterol 1998;33:335-345.
62. Oda T, Elkahloun AG, Pike BL, et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet 1997;16:235-242.
63. Li L, Krantz ID, Deng Y, et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet 1997;16:243-251.
64. Berman L, Markowitz J, Kahn E, et al. Benign recurrent intrahepatic cholestasis and progressive familial intrahepatic cholestasis linked to PFIC1: points on a continuum [abstract]. Hepatology 1997;26:384A.
65. Alonso EM, Snover DC, Montag A, Freese DK, Whitington PF. Histologic pathology of the liver in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 1994;18:128-133.
66. De Koning TJ, Sandkuijl LA, De Schryver JEAR, Hennekam EAM, Beemer FA, Houwen RHJ. Autosomal-recessive inheritance of benign recurrent intrahepatic cholestasis. Am J Med Genet 1995;57:479-482.
67. Houwen RHJ, Baharloo S, Blankenship K, et al. Genome screening by searching for shared segments: Mapping a gene for benign recurrent intrahepatic cholestasis. Nat Genet 1994;8:380-386.
68. Carlton VEH, Knisely AS, Freimer NB. Mapping of a locus for progressive familial intrahepatic cholestasis (Byler disease) to 18q21-q22, the benign recurrent intrahepatic cholestasis region. Hum Mol Genet 1995;4:1049-1053.
69. Strautnieks SS, Kagalwalla AF, Tanner MS, Gardiner RM, Thompson RJ. Locus heterogeneity in progressive familial intrahepatic cholestasis. J Med Genet 1996;33:833-836.
70. Arnell H, Nemeth A, Annerén G, Dahl N. Progressive familial intrahepatic cholestasis (PFIC): evidence for genetic heterogeneity by exclusion of linkage to chromosome 18q21-q22. Hum Genet 1997;100:378-381.
71. Bull LN, Carlton VEH, Stricker NL, et al. Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity. Hepatology 1997;26: 155-164.
72. Tazawa Y. Byler byou. Syoukakika 1988;9:543-550.
73. Lovisetto P, Raviolo P, Rizzetto M, Marchi L, Actis GC, Verme G. Benign recurrent intrahepatic cholestasis: a clinico-pathologic study. Ric Clin Lab 1990;20:19-27.
74. Bourke B, Goggin N, Walsh D, Kennedy S, Setchell KDR, Drumm B. Byler-like familial cholestasis in an extended kindred. Arch Dis Child 1996;75:223-227.
75. Bull LN, Freimer NB, Balistreri WF, et al. A non-Amish infant with true Byler disease [abstract]. Pediatr Pathol Lab Med 1997;17:522-523.
76. Sinke RJ, Carlton VEH, Juijn JA, et al. Benign recurrent intrahepatic cholestasis (BRIC): evidence of genetic heterogeneity and delimitation of the BRIC locus to a 7-cM interval between D18S69 and D18S64. Hum Genet 1997; 100:382-387.
77. Bull LN, Juijn JA, Liao M, et al. Fine-resolution mapping by haplotype evaluation: the examples of PFIC1 and BRIC. Hum Genet 1999;104:241-248.
78. Bull LN, van Eijk MJT, Pawlikowska L, et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet 1998;18:219-223.
79. Mutero A, Bull LN, Pawlikowska L, Freimer NB, Scharschmidt BF, Lomri N. Cloning and tissue distribution of the rat homologue of the human gene involved in familial intrahepatic cholestasis type 1 [abstract]. Hepatology 1998;28:530A.
80. Strautnieks SS, Kagalwalla AF, Tanner MS, et al. Identification of a locus for progressive familial intrahepatic cholestasis PFIC2 on chromosome 2q24. Am J Hum Genet 1997;61:630-633.
81. Childs S, Yeh RL, Georges E, Ling V. Identification of a sister gene to P-glycoprotein. Cancer Res 1995;55:2029-2034.
82. Childs S, Yeh RL, Hui D, Ling V. Taxol resistance mediated by transfection of the liver-specific sister gene of P-glycoprotein. Cancer Res 1998;58:4160-4167.
83. Gerloff T, Stieger B, Hagenbuch B, et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 1998;273:10046-10050.
84. Strautnieks SS, Bull LN, Knisely AS, et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 1998;20: 233-238.
85. Nakanuma Y, Hoso M, Sanzen T, Sasaki M. Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply. Microsc Res Tech 1997;38:552-570.
86. Vos TA, Hooiveld GJEJ, Koning H, et al. Up-regulation of the multidrug resistance genes, mrp1 and mdr1b, and down-regulation of the organic anion transporter, mrp2, and the bile salt transporter, spgp, in endotoxemic rat liver. Hepatology 1998;28:1637-1644.
87. Lazaridis KN, Pham L, Tietz P, et al. Rat cholangiocytes absorb bile acids at their apical domain via the ileal sodium-dependent bile acid transporter. J Clin Invest 1997;100:2714-2721.
88. Scholz J, Bause H, Reymann A, Dürig M. Zur Behandlung mit Clonidin bei kurzdarmsyndrombedingter therapiere-fraktärer Diarrhö. Anästhesiol Intensivmed Notfallmed Schmerzther 1991;26:265-269.
89. Knisely AS, Boyle JT, Naylor EW, Klinger K, Freimer NB, Kocoshis S. Pancreatic dysfunction in Byler disease [abstract]. J Pediatr Gastroenterol Nutr 1995;21:328.
90. Lloyd-Still JD. Familial cholestasis with elevated sweat electrolyte concentrations. J Pediatr 1981;99:580-583.
91. Knisely AS, Agostini RM, Zitelli BJ, Kocoshis SA, Boyle JT. Byler's syndrome [letter]. Arch Dis Child 1997;77:276-277.
92. de Vree JML, Romijn JA, Mok KS, et al. Lack of enteral nutrition during critical illness is associated with profound decrements in biliary lipid concentrations. Am J Clin Nutr 1999;70:70-77.
93. Lammert F, Beier DR, Wang DO-H, Carey MC, Paigen B, Cohen DE. Genetic mapping of hepatocanalicular transporters establishes sister-P-glycoprotein (spgp) as a candidate for the major gallstone gene (Lith1) [abstract]. Hepatology 1997;26:358A.
94. Chatila R, Bergasa NV, Lagarde S, West AB. Intractable cough and abnormal pulmonary function in benign recurrent intrahepatic cholestasis. Am J Gastroenterol 1996;91: 2215-2219.
95. Cissarek T, Schumacher B, Schwöbel H, Sarbia M, Neuhaus H. Verlauf einer benignen rekurrierenden intrahepatischen Cholestase (Summerskill-Walshe-Tygstrup-Syndrom) über 46 Jahre. Z Gastroenterol 1998;36:379-383.
96. Eiberg H, Nielsen I-M. Linkage of cholestasis familiaris groenlandica/Byler-like disease to chromosome 18. Int J Circumpolar Health in press.
97. Ornvold K, Nielsen I-M, Poulsen H. Fatal familial cholestatic syndrome in Greenland Eskimo children: a histomorphological analysis of 16 cases. Virchows Arch A Pathol Anat Histopathol 1989;415:275-281.
98. Maksimak M, O'Connell NC, Setchell KDR, et al. Evidence for a novel form of progressive intrahepatic familial cholestasis in a child of Amish descent [abstract]. Hepatology 1997;26:555A.
99. Morton DH, Salen G, Batta AK, et al. Abnormal hepatic sinusoidal bile acid transport in an Amish kindred is not linked to FIC1 and is improved by ursodiol. Gastroenterology in press.
100. Ye S, Cole-Strauss AC, Frank B, Kmiec EB. Targeted gene correction: a new strategy for molecular medicine. Mol Med Today 1998;4:431-437.